Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword? - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep;280(17):4131-48.
doi: 10.1111/febs.12338. Epub 2013 Jun 18.

Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?

Pura Muñoz-Cánoves  1 , Camilla Scheele, Bente K Pedersen, Antonio L Serrano
Affiliations
Free PMC article
Review

Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?

Pura Muñoz-Cánoves et al. FEBS J. 2013 Sep.
Free PMC article

Abstract

Interleukin (IL)-6 is a cytokine with pleiotropic functions in different tissues and organs. Skeletal muscle produces and releases significant levels of IL-6 after prolonged exercise and is therefore considered as a myokine. Muscle is also an important target of the cytokine. IL-6 signaling has been associated with stimulation of hypertrophic muscle growth and myogenesis through regulation of the proliferative capacity of muscle stem cells. Additional beneficial effects of IL-6 include regulation of energy metabolism, which is related to the capacity of actively contracting muscle to synthesize and release IL-6. Paradoxically, deleterious actions for IL-6 have also been proposed, such as promotion of atrophy and muscle wasting. We review the current evidence for these apparently contradictory effects, the mechanisms involved and discuss their possible biological implications.

Keywords: IL-6; growth/atrophy; inflammation; metabolism; myogenesis; myokine; regeneration; satellite cell; signaling pathway; skeletal muscle.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Pedersen BK & Febbraio MA (2008) Muscle as an endocrine organ: focus on muscle‐derived interleukin‐6. Physiol Rev 88, 1379–1406 - PubMed
    1. Broholm C & Pedersen BK (2010) Leukaemia inhibitory factor – an exercise‐induced myokine. Exerc Immunol Rev 16, 77–85 - PubMed
    1. Broholm C, Laye MJ, Brandt C, Vadalasetty R, Pilegaard H, Pedersen BK & Scheele C (2011) LIF is a contraction‐induced myokine stimulating human myocyte proliferation. J Appl Physiol 111, 251–259 - PubMed
    1. Pedersen BK & Febbraio MA (2012) Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 8, 457–465 - PubMed
    1. Hirano T (1998) Interleukin‐6 and its receptor: ten years later. Int Rev Immunol 16, 249–284 - PubMed

Publication types